Facility footprint
Animal models
Number of clients
Professional Staff
KCI Biotech is a preclinical CRO with 40,000+㎡ of AAALAC-accredited facilities. Our platforms support multiple species, 500+ disease models, and BSL-2/ABSL-2 pathogen research covering 100+ microorganisms, along with pathology and toxicology services. With 1,000+ partners and 200+ regulatory projects, we are recognized among the top CRO companies for comprehensive drug development expertise.
KCI Biotech provides a full range of preclinical new drug development services for global pharmaceutical companies and research institutions, and establishes a professional and efficient drug development evaluation system!
Our professional, integrated R&D team has extensive experience in in vivo pharmacology and pharmacodynamics evaluation. Adhering to a professional spirit of integrity and excellence, we provide comprehensive preclinical drug development services to global pharmaceutical companies and research institutions.
We value your CRO consulting needs and are committed to providing customized solutions to meet your drug discovery and development needs. If you have any questions, need more information, or are interested in exploring potential collaboration opportunities, simply leave a message and our team of experts will be at your service.
Suzhou site
Small Animal Laboratory
10000㎡
Nantong-Haimen site
Large Animal Laboratory
7600㎡
Nantong-Haimen site
Animal Breeding Center
22400㎡
Sit non mauris aenean sem platea tortor est. Tincidunt elit ut varius sit sit lorem aliquam. Morbi metus sem elit dignissim.
Surgeon
Surgeon
Introduction Acute Lung Injury (ALI) is a clinical syndrome induced by multiple factors, characterized by severe hypoxemia, decreased lung elasticity and significant pulmonary edema. In
About KAL · Deep Expertise Setting an Industry Benchmark JIANGSU KAL BIOTECH INC. (“KAL Biotech”) is a nationally certified enterprise specializing in the standardized breeding and supply of
Introduction “Progressive aggravation of proteinuria, decreased glomerular filtration rate, edema, fatigue…” These are among the most concerning complications for hundreds of millions of diabetic patients
Introduction Interstitial lung fibrosis is a chronic, progressive, and irreversible lung disease characterized by interstitial inflammation and excessive collagen deposition. It is known as the
Introduction As the “core organ” of human metabolism, the liver’s lipid metabolism status directly reflects the body’s health level, and TC (total cholesterol) and TG
Introduction Osteoarthritis (OA) is a common degenerative joint disease, especially the most common knee osteoarthritis, which is mainly driven by “degeneration”. The main manifestations include
From Inquiry, documentation, execution, QC/CA to Report.
See the chart of our cooperation steps. Feel free to contact our team and set a meeting together.
ELISA, FACS Analysis, LC/MS/MS, etc.
Yes. Not only are we AAALAC Accredited, we also have a strong GLP-compliant quality system that can perform histology and pathology internally. With our professional CRO expert team’s support, we are hoping to help you accelerate the process of new drug development.
We have two AAALAC international accredited animal facilities in Suzhou and Nantong, totaling over 40,000 square meters, capable of meeting the needs of various preclinical studies.
We maintain a comprehensive laboratory animal platform, including mice, hamsters, guinea pigs, rabbits, cats, dogs, pigs, ferrets, and non-human primates.
Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china
